[1] GENTAROH SUZUKI. In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists.[J]. Journal of Pharmacology and Experimental Therapeutics, 2007, 323 1: 147-156. DOI:
10.1124/jpet.107.124701[2] COLLEEN M NISWENDER. Context-dependent pharmacology exhibited by negative allosteric modulators of metabotropic glutamate receptor 7.[J]. Molecular Pharmacology, 2010, 77 3: 459-468. DOI:
10.1124/mol.109.058768[3] XIA LI. Metabotropic Glutamate Receptor 7 Modulates the Rewarding Effects of Cocaine in Rats: Involvement of a Ventral Pallidal GABAergic Mechanism[J]. Neuropsychopharmacology, 2009, 34 7: 1783-1796. DOI:
10.1038/npp.2008.236[4] ABIGAIL BENN E S J R. Investigating glutamatergic mechanism in attention and impulse control using rats in a modified 5-choice serial reaction time task.[J]. PLoS ONE, 2014: e115374. DOI:
10.1371/journal.pone.0115374[5] ENZA PALAZZO. MMPIP, an mGluR7-selective negative allosteric modulator, alleviates pain and normalizes affective and cognitive behavior in neuropathic mice.[J]. PAIN?, 2015, 156 6: 1060-1073. DOI:
10.1097/j.pain.0000000000000150[6] KAMMERMEIER P J. Constitutive activity of metabotropic glutamate receptor 7.[J]. BMC Neuroscience, 2015, 16: 17. DOI:
10.1186/s12868-015-0154-6